Promosyon programı Idorsia Ltd
Gelişmiş program
Basit grafik
Şirket hakkında Idorsia Ltd
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. daha fazla ayrıntıIndustry | Biotechnology |
---|---|
Sector | Health Care |
Валюта | usd |
Валюта отчета | chf |
Сайт | https://www.idorsia.com |
Цена ао | 1.15 |
Günlük fiyat değişimi: | 0% (1.05) |
---|---|
Haftalık fiyat değişimi: | -19.85% (1.31) |
Aylık fiyat değişimi: | +40% (0.75) |
3 ayda fiyat değişimi: | +50% (0.7) |
Altı ayda fiyat değişimi: | -59.46% (2.59) |
Yıllık fiyat değişimi: | -60.23% (2.64) |
3 yılda fiyat değişimi: | -94.21% (18.15) |
5 yılda fiyat değişimi: | -96.18% (27.5) |
Yılbaşından bu yana fiyat değişimi: | +38.16% (0.76) |
|
Hafife alma
|
Yeterlik
|
|||||||||||||||||||||||||||||||||||||
Temettüler
|
Görev
|
Büyüme dürtüsü
|
Kurumlar | Hacim | Paylaşmak, % |
---|---|---|
Fidelity Select Portfolios - Biotechnology | 4866770 | 2.58 |
Smallcap World Fund | 2270994 | 1.2 |
Vanguard International Stock Index-Total Intl Stock Indx | 1627551 | 0.86 |
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 958060 | 0.51 |
iShares Core MSCI EAFE ETF | 628695 | 0.33 |
Fidelity Growth Company Fund | 623409 | 0.33 |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 479318 | 0.25 |
iShares MSCI EAFE Small Cap ETF | 426739 | 0.23 |
Vanguard International Stock Index-Vanguard European Stock Index | 252174 | 0.13 |
Schwab Strategic Tr-Schwab International Small Cap Equity ETF | 238962 | 0.13 |
Süpervizör | İş unvanı | Ödeme | Doğum yılı |
---|---|---|---|
Mr. Jean-Paul Clozel M.D. | CEO & Chairman of the Board | 956.86k | 1955 (70 yıllar) |
Dr. Martine Clozel | Executive VP & Chief Scientific Officer | N/A | 1955 (70 yıllar) |
Mr. Andrew C. Weiss | Senior VP and Head of Investor Relations & Corporate Communications | N/A | 1968 (57 yıllar) |
Mr. Julien Gander L.L.M. | Senior VP, Group General Counsel & Company Secretary | N/A | 1979 (46 yıllar) |
Mr. Alexander Khatuntsev | Senior VP & Head of Global Human Resources | N/A | 1978 (47 yıllar) |
Dr. Guy Braunstein M.D. | Executive VP & Chief Medical Officer | N/A | 1956 (69 yıllar) |
Mr. Olivier Lambert | Senior VP & Head of Technical Operations | N/A | 1966 (59 yıllar) |
Mr. Markus A. Riederer | Senior VP & Head of Drug Discovery Biology | N/A | 1962 (63 yıl) |
Mr. Alberto Gimona M.D. | Executive VP & Head of Global Clinical Development | N/A | 1960 (65 yıllar) |
Mr. Andre C. Muller | Executive VP & CFO | 1963 (62 yıl) |
Adres: Switzerland, Allschwil, Hegenheimermattweg 91 - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.idorsia.com
Web sitesi: https://www.idorsia.com